Clinical Leader Webinar

  1. Plain Language Summaries A Necessity For Global Transparency 2/19/2026

    As regulatory authorities and industry stakeholders increasingly prioritize accessible communication, PLS are becoming not only a best practice but, in many regions, an emerging requirement.

  2. Measuring Treatment Tolerability In Oncology: Expert Panel Discussion 2/19/2026

    Learn how to synthesize individual symptomatic data into a comprehensive narrative of tolerability, ultimately enhancing the clinical value and regulatory positioning of your oncology assets.

  3. Establishing Hydrogels In Lab Robotics 2/11/2026

    Explore emerging hydrogel trends, entrepreneurship, and AI in biotech with the CEO at GelTech Labs.

  4. From 3 Meetings To 1: Remove Bottlenecks With AI-Enabled eCOA 2/10/2026

    Learn how AI-enabled eCOA can reduce complexity in trial setup by cutting unnecessary meetings, speeding execution, and helping teams focus on what matters most.

  5. Charting The Path To First-In-Human: Strategic Readiness For Early Clinical Success 2/10/2026

    Gain a comprehensive, end-to-end perspective on the journey to first-in-human and understand how early decisions influence downstream success.

  6. Accelerating Clinical Trials Through Streamlined Confidential Disclosure Agreements 2/9/2026

    In this presentation, Dr. Christine Senn addresses the persistent challenge of study startup delays by focusing on a primary legal hurdle: the Confidential Disclosure Agreement (CDA).

  7. A Novel Digital Measure For Tracking Disease Progression In DMD 2/6/2026
  8. Embedding AI And Critical IRB Operations Data To Drive Intelligent Study Design 1/28/2026

    Explore how modern clinical trial design is being transformed by a rich array of data sources through this clear roadmap for navigating the evolving complexities of the industry.

  9. Fast-Track Innovation, Address CMC Challenges In Expedited Pathways 1/26/2026

    Learn to overcome solubility challenges and utilize flexible development strategies to transition innovative treatments from early-phase trials to commercialization while ensuring patient safety.

  10. Unified Data + Trustworthy AI Drives Strategic Precision 1/25/2026

    Data quality and governance underpin portfolio, clinical trial, and commercial decisions. Combined with trustworthy, explainable AI, they enable complete insights for optimization, feasibility, forecasting, and planning.